v3.26.1
Cover
Jul. 29, 2026
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Amendment Description This Amendment No. 1 (this “Amendment”) to the Current Report on Form 8-K originally filed by Sanara MedTech Inc. (the “Company”) with the Securities and Exchange Commission on July 29, 2026 (the “Original Report”) is being filed to amend and restate the Original Report. The only change to the Original Report is to correct an error in Item 1.01 in the Original Report that inadvertently reported (i) the amount of the termination fee payable by the Company in certain circumstances as $22,540,785.00 as opposed to the correct termination fee of $9,660,336.00 and (ii) the amount of the termination fee payable by MiMedx Group, Inc. in certain circumstances as $9,660,336.00 as opposed to the correct termination fee of $22,540,785.00.
Document Period End Date Jul. 29, 2026
Entity File Number 001-39678
Entity Registrant Name SANARA MEDTECH INC.
Entity Central Index Key 0000714256
Entity Tax Identification Number 59-2219994
Entity Incorporation, State or Country Code TX
Entity Address, Address Line One 1200 Summit Avenue
Entity Address, Address Line Two Suite 414
Entity Address, City or Town Fort Worth
Entity Address, State or Province TX
Entity Address, Postal Zip Code 76102
City Area Code (817)
Local Phone Number 529-2300
Written Communications true
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 Par Value
Trading Symbol SMTI
Security Exchange Name NASDAQ
Entity Emerging Growth Company false